Spinocerebellar ataxia type 3: from pathogenesis to promising therapeutics

Trends Mol Med. 2025 Nov;31(11):1065-1066. doi: 10.1016/j.molmed.2025.06.007. Epub 2025 Jul 23.
No abstract available

Keywords: Machado-Joseph disease; gene silencing; polyglutamine disorders; spinocerebellar ataxia type 3; therapeutics.